Tag: NASDAQIBRX

Investment Strategies

ImmunityBio Stock: Still Flashing Signs Life After Another ANKTIVA Approval (NASDAQ:IBRX)

21/07/2025
mhsj

This article was written by Follow Biologics is a full-time healthcare investor who developed a passion…

Asset Allocation

ImmunityBio: Getting Whiplash After FDA’s Refusal To File For Anktiva’s sBLA (NASDAQ:IBRX)

05/05/2025
mhsj

This article was written by Follow Biologics is a full-time healthcare investor who developed a passion…